We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ALSEN.PA

Price
0.34
Stock movement down
-0.03 (-7.25%)
Company name
Sensorion SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Biotechnology
Market cap
101.74M
Ent value
32.46M
Price/Sales
11.69
Price/Book
1.22
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-31.32%
1 year return
-53.69%
3 year return
-14.43%
5 year return
-14.96%
10 year return
-27.87%
Last updated: 2025-04-12

DIVIDENDS

ALSEN.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales11.69
Price to Book1.22
EV to Sales3.73

FINANCIALS

Per share

Per share data
Current share count300.12M
EPS (TTM)-0.14
FCF per share (TTM)-0.15

Income statement

Income statement data
Revenue (TTM)8.70M
Gross profit (TTM)7.18M
Operating income (TTM)-24.83M
Net income (TTM)-35.96M
EPS (TTM)-0.14
EPS (1y forward)-0.13

Margins

Margins data
Gross margin (TTM)82.48%
Operating margin (TTM)-285.35%
Profit margin (TTM)-413.31%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash87.34M
Net receivables8.59M
Total current assets97.96M
Goodwill0.00
Intangible assets621.00K
Property, plant and equipment0.00
Total assets101.53M
Accounts payable7.69M
Short/Current long term debt2.35M
Total current liabilities14.17M
Total liabilities18.07M
Shareholder's equity83.46M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-38.29M
Capital expenditures (TTM)1.27M
Free cash flow (TTM)-39.81M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-43.08%
Return on Assets-35.42%
Return on Invested Capital-42.57%
Cash Return on Invested Capital-47.13%

STOCK INFORMATION

Stock chart

Stock price data
Open0.38
Daily high0.41
Daily low0.34
Daily Volume169K
All-time high18.50
1y analyst estimate2.38
Beta1.34
EPS (TTM)-0.14
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
ALSEN.PAS&P500
Current price drop from All-time high-98.17%-12.89%
Highest price drop-98.57%-56.47%
Date of highest drop31 May 20239 Mar 2009
Avg drop from high-84.40%-11.07%
Avg time to new high160 days12 days
Max time to new high2499 days1805 days
COMPANY DETAILS
ALSEN.PA (Sensorion SA) company logo
Marketcap
101.74M
Marketcap category
Small-cap
Description
Sensorion SA, a biotechnology company, develops drug candidates for the treatment of inner ear disorders in France. Its pipeline includes various products in the development stage for restoring, treating, and preventing inner ear related disorders. The company's product portfolio includes SENS-401 SSNHL, which has completed Phase 2 clinical trial for the treatment of Sudden Sensorineural Hearing Loss; SENS-401 CIO that is in Phase 2 clinical trial for the treatment of Cisplatin-Induced Ototoxicity; and SENS-401 Cochlear, which is in Phase 2 clinical trial for the treatment of hearing preservation after cochlear implantation. It is also developing OTOF-GT (SENS-501), a gene therapy development program that has completed Phase 1 clinical trial to restore hearing in people living with Otoferlin deficiency; and GJB2-GT, a gene therapy development program, which is in pre-clinical trial to restore hearing in people living with hearing loss due to mutations in the GJB2 gene. The company was incorporated in 2009 and is headquartered in Montpellier, France.
Employees
61
Website
https://www.sensorion.com
Investor relations
-
SEC filings
ALSEN.PA SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved